Posters

Search Title by author or title

Visiual functions of binocular implantation of a new trifocal intraocular lens

Poster Details

First Author: H.Aslankara TURKEY

Co Author(s):                        

Abstract Details

Purpose:

To evaluate the clinical outcomes following bilateral implantation of Optiflex Trio intra ocular lens (IOL).

Setting:

Private Gozakademi Eye Hospital

Methods:

This prospective, non comparative, non-randomized study included 100 eyes of 50 patients operated on by two surgeons(HA,SM) undergoing bilateral cataract or refractive lens exchange surgery between December 2018-August 2019. Exclusion criteria were the presence of other ocular pathologies or preoperative astigmatism greater than 1.5 diopters(D). Six month after surgery, manifest refraction, visual acuity; uncorrected distance visual acuity(UDVA), corrected distance visual acuity(CDVA), uncorrected intermediate visual acuity(UIVA,70cm) and uncorrected near visual acuity(UNVA,40cm) were evaluated. The defocus curves, presence of dysphotopsia, need for spectacles, the presence of posterior capsule opacification and visual function test-14 were assessed at 6 months after surgery.

Results:

The mean binocular UDVA was 0.02± 0.04 logmar, UIVA 0.07 ± 0.08 logmar and UNVA 0.06 ± 0.06 logmar postoperatively. All patients had an uncorrected visual acuity of 0.2 logmar or better for all distances. The IOL was able to provide visual acuity 0.1 logmar or better between defocus levels of +0.5 D to -3.00 D whereas showed two peaks at 0.00 D and -1.50 D. Complete spectacle independence was reported in 98% of the patients. The mean VF-14 test result was 97.7±2.2 (93.2-100). Only 4 patients (8%) reported seeing bothersome halos. The presence of posterior capsule opacification was noted in 10 eyes (10%) whereas Nd:Yag capsulotomy was required in 5 eyes.

Conclusions:

Implantation of Optiflex Trio IOL provided excellent distance, intermediate and near visual outcomes with nondisturbing photic phenomen, high spectacle independence and patient satisfaction.

Financial Disclosure:

None

Back to Poster listing